Letter: New-onset psoriasis associated with adalimumab: A report of two cases

Dermatology Online Journal

Volumn 17, Issue 9, 2011, Pages 15-

  Glenn, Candace J ^a   Kobraei, Katherina B ^b   Russo, Jacqueline J ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; BACLOFEN; CETIRIZINE; COLCHICINE; CORTICOSTEROID; FLUOCINONIDE; HYDROXYZINE; LOSARTAN; METHYLPREDNISOLONE; STEROID; TRAMADOL; TRIAMCINOLONE; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ABSENCE OF SIDE EFFECTS; ADULT; ANAMNESIS; ANKYLOSING SPONDYLITIS; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; DOCTOR PATIENT RELATION; DRUG WITHDRAWAL; EPIDERMIS HYPERPLASIA; HUMAN; HUMAN TISSUE; LEG; LETTER; LYMPHOCYTIC INFILTRATION; MALE; MEDICAL HISTORY; PAPULE; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRURITUS; PSORIASIS; RASH; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SYSTEMIC THERAPY; TREATMENT DURATION; CHEMICALLY INDUCED DISORDER; MIDDLE AGED;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; ARTHRITIS, RHEUMATOID; CROHN DISEASE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SPONDYLITIS, ANKYLOSING;

EID: 80053032963     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Park JJ, Lee SC. A case of tumor necrosis factor-alpha inhibitors-induced pustular psoriasis. Ann Dermatol. 2010 May;22(2):212-5. [PubMed]
2. Egnatios G, Warthan MM, Pariser R, et al. Pustular psoriasis following treatment of rheumatoid arthritis with TNF-alpha inhibitors. J Drugs Dermatol. 2008 Oct;7(10):975-7. [PubMed]
3. Collamer AN, Guerrero KT, Henning JS, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum. 2008;59:996-1001. [PubMed]
4. De Gannes GC, Ghoreishi M, Pope J, Russell A, Bell D, Adams S, Shojania K, Martinka M, Dutz JP. Psoriasis and pustular dermatitis triggered by TNF-inhibitors in patients with rheumatologic conditions. Arch Dermatol. 2007 Feb;143(2):223-31. [PubMed]
5. Mease P. TNFalpha therapy in psoriatic arthritis and psoriasis. Ann Rheum Dis. 2004 Jul;63(7):755-8. [PubMed]
6. Harrison MJ, Dixon WG, Watson KD, King Y, Groves R, Hyrich KL, Symmons DP; British Society for Rheumatology Biologics Register Control Centre Consortium. Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-α therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2009 Feb;68(2):209-15. [PubMed]
7. Collamer AN, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum. 2010 Dec;40(3):233-40. [PubMed]
8. Cohen JD, Bournerias I, Buffard V, Paufler A, Chevalier X, Bagot M, Claudepierre P. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series. J Rheumatol. 2007 Feb;34(2):380-5. [PubMed]
9. Kary S, Worm M, Audring H, Huscher D, Renelt M, Sörensen H, Ständer E, Maass U, Lee H, Sterry W, Burmester GR. New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. Ann Rheum Dis. 2006 Mar;65(3):405-7. [PubMed]
10. Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A. Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum. 2005 Aug;52(8):2513-8. [PubMed]